Overview

• Healthcare tech platform's Q4 revenue rose 7.4%, beating analyst expectations

• Adjusted EBITDA for Q4 beat analyst expectations

• Company completed acquisitions of Virsys12 and MissionCare Collective

Outlook

• HealthStream projects 2026 revenue between $323 mln and $330 mln

• Company expects 2026 net income between $20.4 mln and $22.8 mln

• HealthStream anticipates 2026 adjusted EBITDA between $73 mln and $77 mln

Result Drivers

• REVENUE GROWTH - Record Q4 revenue driven by a 7.4% increase, primarily from subscription revenue growth

Company press release: ID:nBwbX5Jvza

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the software peer group is "buy"

• Wall Street's median 12-month price target for HealthStream Inc is $32.50, about 59.7% above its February 20 closing price of $20.35

• The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 33 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.